These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 21246222)

  • 1. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study.
    Bentwich J; Dobronevsky E; Aichenbaum S; Shorer R; Peretz R; Khaigrekht M; Marton RG; Rabey JM
    J Neural Transm (Vienna); 2011 Mar; 118(3):463-71. PubMed ID: 21246222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study.
    Rabey JM; Dobronevsky E; Aichenbaum S; Gonen O; Marton RG; Khaigrekht M
    J Neural Transm (Vienna); 2013 May; 120(5):813-9. PubMed ID: 23076723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.
    Rabey JM; Dobronevsky E
    J Neural Transm (Vienna); 2016 Dec; 123(12):1449-1455. PubMed ID: 27631152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Loy C; Schneider L
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD001747. PubMed ID: 16437436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
    Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
    CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine for Alzheimer's disease.
    Loy C; Schneider L
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001747. PubMed ID: 15495017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease.
    Nguyen JP; Suarez A; Kemoun G; Meignier M; Le Saout E; Damier P; Nizard J; Lefaucheur JP
    Neurophysiol Clin; 2017 Feb; 47(1):47-53. PubMed ID: 28161090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.
    Modrego PJ; Rios C; Pérez Trullen JM; García-Gómara MJ; Errea JM
    CNS Drugs; 2009; 23(3):253-60. PubMed ID: 19320533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.
    Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Petanceska S; Browne P; Wassar D; Johnson-Traver S; Lochhead J; Ziolkowski C
    Curr Alzheimer Res; 2005 Jul; 2(3):343-53. PubMed ID: 15974900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients.
    Zhao J; Li Z; Cong Y; Zhang J; Tan M; Zhang H; Geng N; Li M; Yu W; Shan P
    Oncotarget; 2017 May; 8(20):33864-33871. PubMed ID: 27823981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.
    Blesa R; Davidson M; Kurz A; Reichman W; van Baelen B; Schwalen S
    Dement Geriatr Cogn Disord; 2003; 15(2):79-87. PubMed ID: 12566596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Transcranial Direct Current Stimulation Combined with Cognitive Training in the Treatment of Apathy in Patients with Alzheimer's Disease: Study Protocol for a Randomized Trial.
    Nguyen JP; Boutoleau-Bretonniere C; Lefaucheur JP; Suarez A; Gaillard H; Chapelet G; Abad S; Van Langhenhove A; Nizard J; de Decker L
    Rev Recent Clin Trials; 2018; 13(4):319-327. PubMed ID: 29658441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Alzheimer's Disease with Repetitive Transcranial Magnetic Stimulation Combined with Cognitive Training: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study.
    Lee J; Choi BH; Oh E; Sohn EH; Lee AY
    J Clin Neurol; 2016 Jan; 12(1):57-64. PubMed ID: 26365021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
    Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
    Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-frequency repetitive transcranial magnetic stimulation combined with cognitive training improves cognitive function and cortical metabolic ratios in Alzheimer's disease.
    Zhang F; Qin Y; Xie L; Zheng C; Huang X; Zhang M
    J Neural Transm (Vienna); 2019 Aug; 126(8):1081-1094. PubMed ID: 31292734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
    Ibarria M; Alegret M; Valero S; Morera A; Guitart M; Cañabate P; Moreno M; Lara S; Diego S; Hernández J; Tantinyá N; Vera M; Hernández I; Becker JT; Ruíz A; Boada M; Tárraga L
    J Alzheimers Dis; 2016; 50(2):559-66. PubMed ID: 26757182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, sham-controlled, clinical trial of repetitive transcranial magnetic stimulation for patients with Alzheimer's dementia in Japan.
    Saitoh Y; Hosomi K; Mano T; Takeya Y; Tagami S; Mori N; Matsugi A; Jono Y; Harada H; Yamada T; Miyake A
    Front Aging Neurosci; 2022; 14():993306. PubMed ID: 36313021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.